EMPIRE STATE REALTY TRUST-A (ESRT) Stock Fundamental Analysis

USA New York Stock Exchange NYSE:ESRT • US2921041065

6.8 USD
+0.12 (+1.8%)
At close: Feb 10, 2026
6.8 USD
0 (0%)
After Hours: 2/10/2026, 4:20:03 PM
Fundamental Rating

4

Overall ESRT gets a fundamental rating of 4 out of 10. We evaluated ESRT against 122 industry peers in the Diversified REITs industry. ESRT has only an average score on both its financial health and profitability. ESRT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ESRT was profitable.
  • In the past year ESRT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ESRT reported negative net income in multiple years.
  • In the past 5 years ESRT always reported a positive cash flow from operatings.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • ESRT has a Return On Assets of 0.85%. This is comparable to the rest of the industry: ESRT outperforms 52.46% of its industry peers.
  • Looking at the Return On Equity, with a value of 3.25%, ESRT is in line with its industry, outperforming 57.38% of the companies in the same industry.
  • ESRT has a Return On Invested Capital (2.87%) which is in line with its industry peers.
  • ESRT had an Average Return On Invested Capital over the past 3 years of 2.75%. This is in line with the industry average of 3.07%.
  • The 3 year average ROIC (2.75%) for ESRT is below the current ROIC(2.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROIC 2.87%
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4

1.3 Margins

  • The Profit Margin of ESRT (4.55%) is comparable to the rest of the industry.
  • ESRT's Profit Margin has declined in the last couple of years.
  • ESRT has a Operating Margin (18.68%) which is comparable to the rest of the industry.
  • ESRT's Operating Margin has been stable in the last couple of years.
  • ESRT has a worse Gross Margin (54.04%) than 72.95% of its industry peers.
  • In the last couple of years the Gross Margin of ESRT has remained more or less at the same level.
Industry RankSector Rank
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

4

2. Health

2.1 Basic Checks

  • ESRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ESRT has been increased compared to 1 year ago.
  • ESRT has less shares outstanding than it did 5 years ago.
  • ESRT has a worse debt/assets ratio than last year.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.59, we must say that ESRT is in the distress zone and has some risk of bankruptcy.
  • ESRT has a Altman-Z score (0.59) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.92 is on the high side and indicates that ESRT has dependencies on debt financing.
  • ESRT's Debt to Equity ratio of 1.92 is on the low side compared to the rest of the industry. ESRT is outperformed by 68.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Altman-Z 0.59
ROIC/WACC0.48
WACC6.03%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ESRT has a Current Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ESRT (2.59) is better than 89.34% of its industry peers.
  • ESRT has a Quick Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • ESRT has a better Quick ratio (2.59) than 89.34% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 37.50% over the past year.
  • Measured over the past years, ESRT shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.83% on average per year.
  • ESRT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.45%.
  • Measured over the past years, ESRT shows a small growth in Revenue. The Revenue has been growing by 0.98% on average per year.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%

3.2 Future

  • The Earnings Per Share is expected to decrease by -37.27% on average over the next years. This is quite bad
  • ESRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.75% yearly.
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

  • ESRT is valuated cheaply with a Price/Earnings ratio of 7.73.
  • Compared to the rest of the industry, the Price/Earnings ratio of ESRT indicates a rather cheap valuation: ESRT is cheaper than 95.08% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of ESRT to the average of the S&P500 Index (28.06), we can say ESRT is valued rather cheaply.
  • The Price/Forward Earnings ratio is 111.11, which means the current valuation is very expensive for ESRT.
  • ESRT's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 27.86. ESRT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 7.73
Fwd PE 111.11
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • 91.80% of the companies in the same industry are more expensive than ESRT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.14
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A cheap valuation may be justified as ESRT's earnings are expected to decrease with -56.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.11%, ESRT has a reasonable but not impressive dividend return.
  • With a Dividend Yield of 2.11, ESRT pays less dividend than the industry average, which is at 6.80. 84.43% of the companies listed in the same industry pay a better dividend than ESRT!
  • ESRT's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.11%

5.2 History

  • The dividend of ESRT decreases each year by -17.38%.
  • ESRT has paid a dividend for at least 10 years, which is a reliable track record.
  • ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • ESRT pays out 79.65% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of ESRT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP79.65%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (2/10/2026, 4:20:03 PM)

After market: 6.8 0 (0%)

6.8

+0.12 (+1.8%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-29
Earnings (Next)02-17
Inst Owners100.46%
Inst Owner Change-1.38%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.16B
Revenue(TTM)766.65M
Net Income(TTM)34.89M
Analysts75
Price Target8.12 (19.41%)
Short Float %3.35%
Short Ratio4.14
Dividend
Industry RankSector Rank
Dividend Yield 2.11%
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP79.65%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.01%
PT rev (3m)-10.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 7.73
Fwd PE 111.11
P/S 1.51
P/FCF N/A
P/OCF 4.36
P/B 1.08
P/tB 4.22
EV/EBITDA 9.14
EPS(TTM)0.88
EY12.94%
EPS(NY)0.06
Fwd EY0.9%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)1.56
OCFY22.91%
SpS4.5
BVpS6.31
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Graham Number11.18
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROCE 3.64%
ROIC 2.87%
ROICexc 2.99%
ROICexgc 3.79%
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
FCFM N/A
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ROICexc(3y)2.99%
ROICexc(5y)2.46%
ROICexgc(3y)3.81%
ROICexgc(5y)3.15%
ROCE(3y)3.48%
ROCE(5y)2.83%
ROICexgc growth 3Y18.9%
ROICexgc growth 5Y-2.68%
ROICexc growth 3Y19.87%
ROICexc growth 5Y-1.77%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Debt/EBITDA 6.18
Cap/Depr 140.72%
Cap/Sales 34.79%
Interest Coverage 1.49
Cash Conversion 79.7%
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 0.59
F-Score6
WACC6.03%
ROIC/WACC0.48
Cap/Depr(3y)133.09%
Cap/Depr(5y)115.91%
Cap/Sales(3y)34.64%
Cap/Sales(5y)32.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%
EBIT growth 1Y-8.53%
EBIT growth 3Y22.28%
EBIT growth 5Y0.51%
EBIT Next Year124.48%
EBIT Next 3Y34.61%
EBIT Next 5Y20.13%
FCF growth 1Y96.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.72%
OCF growth 3Y7.08%
OCF growth 5Y2.32%

EMPIRE STATE REALTY TRUST-A / ESRT FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status for ESRT stock?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


What is the profitability of ESRT stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 4 / 10.


What is the valuation of EMPIRE STATE REALTY TRUST-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EMPIRE STATE REALTY TRUST-A (ESRT) is 7.73 and the Price/Book (PB) ratio is 1.08.


What is the financial health of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.